PHYSICIANS SCIENTIST TRAINING IN SUBSTANCE ABUSE

描述：(申请人摘要) 使用修订后的指导临床科学家发展计划奖 精神病学系物质滥用科(MCSDPA)机制 耶鲁大学医学院要求续订5年 我们的医生科学家培训计划，一直在提供密集的 培训临床和临床前调查的研究方法 吸毒。我们招聘6个教职员工级别的医生职位 在耶鲁大学药物滥用部门服刑3-5年。治疗单位获得临床和 在一组调查人员的指导下进行研究培训 兴趣范围从分子神经生物学到精神流行病学。 有30多个外部资助的研究项目，我们的主题是 研究计划是对创新的开发和评估 药物滥用者的药物和行为治疗。我们的 多学科计划使我们能够进行进展迅速的研究 以及从临床前项目(“BASE”)到临床项目的双向 研究(“床边”)。该计划的培训目标是提供 初级教员级别的内科科学家有机会 在职业生涯的初始阶段投入几乎全职的努力 以学习研究技能和开展研究项目为起点 独立临床医生科学家的职业生涯。在进行初步工作后 在这个项目的支持下，他们将被引导发展 具有科学价值的研究建议(例如，使用第一个 奖励或R01机制)，这将为以下研究提供支持 超出了本计划的期限。

DESCRIPTION: (Applicant's Abstract) Using the revised Mentored Clinical Scientist Development Program Award (MCSDPA) mechanism, the Substance Abuse Division, Department of Psychiatry at Yale University School of Medicine requests a 5 year renewal period for our Physician Scientist Training Program, which has been providing intensive training in research methods for clinical and preclinical investigations on drug abuse. We request 6 positions for faculty level physicians to spend 3-5 years at Yale's Substance Abuse. Treatment Unit obtaining clinical and research training under the mentorship of a team of investigators whose interests range from molecular neurobiology to psychiatric epidemiology. With over 30 externally funded research projects, the central theme of our research program is the development and evaluation of innovative pharmacological and behavioral treatments for substance abusers. Our multidisciplinary program enables us to conduct research that moves rapidly and in both directions from preclinical projects ("bench") to clinical studies ("bedside"). The training goal for this program is to provide physician scientists at the junior faculty level with an opportunity to devote virtually full-time effort during the initial phase of their careers to learning research skills and conducting research projects as a start to careers as independent clinician scientists. After initial work conducted with the support of this program, they will be guided to develop scientifically meritorious research proposals (using, for example, First Award or R01 mechanisms) which will provide support for research that extends beyond the period of this program.